Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jindrich Kopecký"'
Autor:
T. Dolezal, Milada Zemanova, Ondrej Fiala, Lenka Capkova, Jindrich Kopecký, Jindrich Finek, T. Mlcoch, Tomas Buchler, Bohuslav Melichar, Alexandr Poprach, Katerina Kopeckova
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 808, p 808 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 808, p 808 (2020)
Background: The Memorial Sloan&ndash
Kettering Cancer Center (MSKCC) prognostic model has been widely used for the prediction of the outcome of metastatic renal cell carcinoma (mRCC) patients treated with systemic therapies, however, data from l
Kettering Cancer Center (MSKCC) prognostic model has been widely used for the prediction of the outcome of metastatic renal cell carcinoma (mRCC) patients treated with systemic therapies, however, data from l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7b3a7a8e165a452646dfff1858b0cf
https://zenodo.org/record/5464066
https://zenodo.org/record/5464066
Autor:
Jindřich Kopecký, Marek Pásek, Radek Lakomý, Bohuslav Melichar, Ivona Mrazová, Ondřej Kubeček, Monika Arenbergerová, Radmila Lemstrová, Alžběta Švancarová, Vojtěch Tretera, Alžběta Hlodáková, Kamila Žváčková
Publikováno v:
Cancer Medicine, Vol 13, Iss 5, Pp n/a-n/a (2024)
Abstract Background Immunotherapy and targeted therapy are currently two alternative backbones in the therapy of BRAF‐mutated malignant melanoma. However, predictive biomarkers that would help with treatment selection are lacking. Methods This retr
Externí odkaz:
https://doaj.org/article/97e3502a34ea4d9d90c21a532ba6f4ca
Autor:
Radek Lakomy, Jindrich Kopecký, Milada Zemanova, Igor Kiss, Hana Študentová, Ondrej Fiala, Bohuslav Melichar, Katerina Kopeckova, Katarína Petráková, Tomas Buchler, Ondrej Slaby, Renata Chloupková, Alexandr Poprach, Ladislav Dušek, Jindrich Finek
Publikováno v:
Anticancer Research. 38
Background: Pazopanib is approved for the first-line treatment of patients with metastatic renal cell carcinoma (mRCC). The present study was a retrospective registry-based analysis of 426 patients with mRCC treated with pazopanib as first-line targe
Autor:
Jindrich Kopecky, Ondrej Kubecek, Peter Priester, Hana Vosmikova, Eva Cermakova, Aneta Kyllarova
Publikováno v:
Biomedical Papers, Vol 166, Iss 4, Pp 393-404 (2022)
Background. The treatment and prognosis of metastatic melanoma have changed during the last decade to include immunotherapy or targeted therapy as standard therapeutic options for BRAF-mutated melanoma. However, predictive and/or prognostic markers a
Externí odkaz:
https://doaj.org/article/7a0666291c8d4299a76ffccb096069f2
Autor:
Ondřej Kubeček, Jan Laco, Jiří Špaček, Alena Kubečková, Jiří Petera, Iva Selke Krulichová, Aleš Bezrouk, Stanislav Filip, Jindřich Kopecký
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2914-2927 (2021)
Background: Secondary tumors of the ovary (STOs) account for 10–25% of all ovarian malignancies, including metastases from primary gynecological tumors. Colorectal cancer (CRC) has been recognized as one of the most common causes of STOs in Western
Externí odkaz:
https://doaj.org/article/624e3aa44f564ab48754237d1a22b50b
Autor:
Stanislav, Filip, Ladislav, Slovácek, Dagmar, Svecová, Dalibor, Milka, Jindrich, Kopecký, Petr, Priester, Jirí, Petera, Václav, Svoboda
Publikováno v:
Casopis lekaru ceskych. 150(3)
Palliative treatment and related nursing care are currently a major problem in the organization of health care. Outpatient palliative cancer care (OPCC) helps to verify the clinical status of cancer patients and helps to choose the best treatment opt
Autor:
Petr Dvorak, Petr Hoffmann, Michal Balik, Martina Hoffmannova, Jindrich Kopecky, Radka Dvorakova, Marketa Nova
Publikováno v:
Biomedical Papers, Vol 164, Iss 4, Pp 435-443 (2020)
Aims: To retrospectively evaluate the technical features, efficacy, accuracy, appropriate complications, and relationships among monitored parameters of computed tomography-guided biopsies of the retroperitoneum-located processes. Methods: From Decem
Externí odkaz:
https://doaj.org/article/a99c9e2eae54476394bab35f6b4a6c79
Autor:
Konstantinos Kamposioras, Davide Mauri, Konstantinos Papadimitriou, Alan Anthoney, Nadia Hindi, Branka Petricevic, Mario Dambrosio, Antonis Valachis, Pantelis Kountourakis, Jindrich Kopecky, Cvetka Grašič Kuhar, Lazar Popovic, Nataliya P. Chilingirova, George Zarkavelis, Ramon Andrade de Mello, Natalija Dedić Plavetić, Christos Christopoulos, Bianca Mostert, John R. Goffin, Dimitiros Tzachanis, Haytham Hamed Saraireh, Fei Ma, Ida Pavese, Maria Tolia
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
IntroductionPandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support d
Externí odkaz:
https://doaj.org/article/5ef0bdb198064c2d966675fd17816dd2
Publikováno v:
Biomedical Papers, Vol 162, Iss 4, Pp 335-339 (2018)
Background: The standard treatment for metastatic renal cancer is based on vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTor) inhibitors. Compared to other advanced tumors, the treatment of renal cancer is highly affec
Externí odkaz:
https://doaj.org/article/1dd21da999274ce2830ac29558c3791b